Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Farmers Insurance
Healthtrust
Express Scripts
Covington
US Department of Justice
Cantor Fitzgerald
Merck
McKinsey

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072709

« Back to Dashboard

NDA 072709 describes MINOXIDIL, which is a drug marketed by Perrigo Israel, Mutual Pharm, Par Pharm, Royce Labs, Sun Pharm Industries, Usl Pharma, Watson Labs, Watson Labs Inc, Actavis Mid Atlantic, Apotex Inc, Bausch And Lomb, Copley Pharm, Hi Tech Pharma, L Perrigo Co, Sight Pharms, Teva, Wockhardt, Avacor Prods, Perrigo, and Perrigo New York, and is included in twenty-six NDAs. It is available from thirty suppliers. Additional details are available on the MINOXIDIL profile page.

The generic ingredient in MINOXIDIL is minoxidil. There are eight drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Summary for 072709
Tradename:MINOXIDIL
Applicant:Sun Pharm Industries
Ingredient:minoxidil
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 072709
Physiological EffectArteriolar Vasodilation
Medical Subject Heading (MeSH) Categories for 072709
Suppliers and Packaging for NDA: 072709
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MINOXIDIL minoxidil TABLET;ORAL 072709 ANDA AvKARE, Inc. 42291-619 42291-619-90 90 TABLET in 1 BOTTLE (42291-619-90)
MINOXIDIL minoxidil TABLET;ORAL 072709 ANDA AvKARE, Inc. 42291-619 42291-619-01 100 TABLET in 1 BOTTLE (42291-619-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Dec 14, 1995TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Novartis
Cipla
Chinese Patent Office
Covington
Merck
Argus Health
US Army
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot